Sana Biotechnology Valuation
| SANA Stock | USD 7.61 0.14 1.81% |
At this time, the company appears to be undervalued. Sana Biotechnology has a current Real Value of $8.47 per share. The regular price of the company is $7.61. Our model measures the value of Sana Biotechnology from inspecting the company fundamentals such as Return On Equity of -0.77, shares owned by institutions of 89.94 %, and Shares Outstanding of 221.5 M as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Sana Biotechnology's valuation include:
Price Book 6.8625 | Enterprise Value 1.5 B | Enterprise Value Ebitda (6.97) |
Undervalued
Today
Please note that Sana Biotechnology's price fluctuation is slightly risky at this time. Calculation of the real value of Sana Biotechnology is based on 3 months time horizon. Increasing Sana Biotechnology's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Sana Biotechnology is useful when determining the fair value of the Sana stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Sana Biotechnology. Since Sana Biotechnology is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Sana Stock. However, Sana Biotechnology's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 7.61 | Real 8.47 | Target 10.0 | Hype 7.52 | Naive 6.96 |
The real value of Sana Stock, also known as its intrinsic value, is the underlying worth of Sana Biotechnology Company, which is reflected in its stock price. It is based on Sana Biotechnology's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Sana Biotechnology's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Sana Biotechnology's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Sana Biotechnology helps investors to forecast how Sana stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Sana Biotechnology more accurately as focusing exclusively on Sana Biotechnology's fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Sana Biotechnology's intrinsic value based on its ongoing forecasts of Sana Biotechnology's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Sana Biotechnology's closest peers. When choosing an evaluation method for Sana Biotechnology, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Sana Biotechnology Investments |
|
Sana Valuation Trend
Knowing Sana Biotechnology's actual value is paramount for traders to make sound investment determinations. Sana Biotechnology's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Sana Biotechnology's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Sana Biotechnology's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Sana Market Cap
Sana Biotechnology is currently regarded as top stock in market capitalization category among related companies. Market capitalization of Health Care industry is at this time estimated at about 2.31 Billion. Sana Biotechnology totals roughly 1.73 Billion in market capitalization claiming about 75% of equities under Health Care industry.Sana Biotechnology Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Sana Biotechnology's current stock value. Our valuation model uses many indicators to compare Sana Biotechnology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sana Biotechnology competition to find correlations between indicators driving Sana Biotechnology's intrinsic value. More Info.Sana Biotechnology is currently regarded as top stock in price to book category among related companies. It is rated second in beta category among related companies totaling about 0.24 of Beta per Price To Book. The ratio of Price To Book to Beta for Sana Biotechnology is roughly 4.24 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Sana Biotechnology by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Sana Biotechnology's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sana Biotechnology's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Sana Biotechnology's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Sana Biotechnology and how it compares across the competition.
About Sana Biotechnology Valuation
The stock valuation mechanism determines the current worth of Sana Biotechnology on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Sana Biotechnology. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Sana Biotechnology based exclusively on its fundamental and basic technical indicators. By analyzing Sana Biotechnology's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Sana Biotechnology's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Sana Biotechnology. We calculate exposure to Sana Biotechnology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Sana Biotechnology's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -30.9 M | -29.3 M | |
| Pretax Profit Margin | 0.00 | 0.00 | |
| Operating Profit Margin | 0.00 | 0.00 | |
| Net Profit Margin | 0.00 | 0.00 | |
| Gross Profit Margin | 0.00 | 0.00 |
8 Steps to conduct Sana Biotechnology's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Sana Biotechnology's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Sana Biotechnology's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Sana Biotechnology's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Sana Biotechnology's revenue streams: Identify Sana Biotechnology's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Sana Biotechnology's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Sana Biotechnology's growth potential: Evaluate Sana Biotechnology's management, business model, and growth potential.
- Determine Sana Biotechnology's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Sana Biotechnology's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Sana Biotechnology Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Sana Biotechnology does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 194.5 M |
Sana Biotechnology Current Valuation Indicators
Valuation refers to the process of determining the present value of Sana Biotechnology and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Sana we look at many different elements of the entity such as Sana's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Sana Biotechnology's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Sana Biotechnology's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Sana Biotechnology, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Sana Biotechnology's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Sana Biotechnology's worth.When determining whether Sana Biotechnology offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sana Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sana Biotechnology Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sana Biotechnology Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sana Biotechnology. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Sana Stock refer to our How to Trade Sana Stock guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Complementary Tools for Sana Stock analysis
When running Sana Biotechnology's price analysis, check to measure Sana Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sana Biotechnology is operating at the current time. Most of Sana Biotechnology's value examination focuses on studying past and present price action to predict the probability of Sana Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sana Biotechnology's price. Additionally, you may evaluate how the addition of Sana Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |
Is Sana Biotechnology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sana Biotechnology. If investors know Sana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sana Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.48) | Return On Assets (0.31) | Return On Equity (0.77) |
The market value of Sana Biotechnology is measured differently than its book value, which is the value of Sana that is recorded on the company's balance sheet. Investors also form their own opinion of Sana Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Sana Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sana Biotechnology's market value can be influenced by many factors that don't directly affect Sana Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sana Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sana Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sana Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.